- Home
- RNXT vs AURE Comparison
RNXT vs AURE Comparison
Compare RNXT & AURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNXT | AURE |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | Hong Kong |
| Employees | 17 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.4M | 65.4M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RNXT | AURE |
|---|---|---|
| Price | $1.80 | $1.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.25 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 10.5K |
| Earning Date | 05-14-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,123,000.00 | N/A |
| Revenue This Year | $194.66 | N/A |
| Revenue Next Year | $279.78 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $0.18 |
| 52 Week High | $2.59 | $3.53 |
Technical Indicators
Market Signals| Indicator | RNXT | AURE |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 39.93 |
| Support Level | $0.83 | $1.25 |
| Resistance Level | $2.59 | $2.67 |
| Average True Range (ATR) | 0.27 | 0.12 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 36.67 | 27.38 |
Price Performance
Historical ComparisonAbout RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About AURE Prestige Wealth Inc. Class A Ordinary Shares
Aurelion Inc is a Tether Gold (XAUT) Real World Asset (RWA) company focused on developing a business around tokenized gold. XAUT combines the stability of physical gold with the efficiency of blockchain, providing investors access to a tokenized gold reserve that could serve as a haven to inflation, currency devaluation, and crypto volatility. In parallel to building a business around the development of tokenized gold, Aurelion provides wealth management and asset management services.